InfantRisk HCP vs CCHD PulseOx screening

Pregnant and breastfeeding patients deserve safe, effective care. Too often, treatment decisions are clouded by uncertainty. InfantRisk HCP gives healthcare professionals fast, evidence-based guidance on medication safety in pregnancy and lactation—so you can make confident choices in seconds. Developed by leading researchers and clinicians, the app provides: • Quick drug safety ratings (1 = safest, 5 = most hazardous) for pregnancy and breastfeeding • Access to over 70,000 medications with concise, evidence-based summaries • Easy comparison of safety ratings by indication or drug class • A clean, intuitive interface with monthly data updates Are you a parent? Try our companion app, MommyMeds, written with patients in mind. Subscription: $14.99 USD per year Terms of Use: https://www.infantrisk.com/infantrisk-hcp-terms-use Disclaimer: The information in InfantRisk HCP is designed to support—not replace—clinical judgment and individualized patient care.

In 2011, pulse oximetry screening was recommended to improve the detection of critical congenital heart defects in newborns. This application was developed by Children’s Healthcare of Atlanta to aid healthcare professionals in implementing pulse oximetry screening in the newborn nursery. The algorithm is endorsed by the American Academy of Pediatrics and the American Heart Association.